Review of 2022 PSOGI/RENAPE Consensus on HIPEC

Shigeki Kusamura; Aditi Bhatt; Kurt van Der Speeten; Vahan Kepenekian; Martin Hübner; Clarisse Eveno; Ignace de Hingh; Jean-Baptiste Delhorme; Abdelkader Taibi; Laurent Villeneuve; Rea Lo Dico; Brendan Moran; Kim Govaerts; Oliver Zivanovic; Donal Brennan; Cedric Nadeau; Willemien Van Driel; Naoual Bakrin; Pompiliu Piso; Victor J Verwaal; Santiago González-Moreno; Mohammad Alyami; Olivia Sgarbura; Beate Rau; Marcello Deraco; Olivier Glehen

doi:10.1002/jso.27885

Review of 2022 PSOGI/RENAPE Consensus on HIPEC

J Surg Oncol. 2024 Sep 16. doi: 10.1002/jso.27885. Online ahead of print.

Authors

Shigeki Kusamura¹, Aditi Bhatt², Kurt van Der Speeten³, Vahan Kepenekian^{4

5}, Martin Hübner⁶, Clarisse Eveno⁷, Ignace de Hingh⁸, Jean-Baptiste Delhorme⁹, Abdelkader Taibi^{10

11}, Laurent Villeneuve¹², Rea Lo Dico¹³, Brendan Moran¹⁴, Kim Govaerts³, Oliver Zivanovic¹⁵, Donal Brennan¹⁶, Cedric Nadeau¹⁷, Willemien Van Driel¹⁸, Naoual Bakrin¹⁹, Pompiliu Piso²⁰, Victor J Verwaal²¹, Santiago González-Moreno²², Mohammad Alyami²³, Olivia Sgarbura²⁴, Beate Rau²⁵, Marcello Deraco¹, Olivier Glehen^{4

5}

Affiliations

¹ PSM Unit, Department of Surgical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
² Department of Surgical Oncology, KD Hospital, Ahmedabad, India.
³ Department of Abdominal and Oncological Surgery, Ziekenhuis Oost Limburg (ZOL), Genk, Belgium.
⁴ Department of Oncological Surgery, Hôpital Lyon Sud, Hospices Civils de Lyon, Lyon, France.
⁵ CICLY, Université Claude Bernard Lyon 1, Lyon, France.
⁶ Department of Visceral Surgery, Lausanne University Hospital (CHUV), University of Lausanne (UNIL), Lausanne, Switzerland.
⁷ Department of Digestive and Oncological Surgery, University Lille, Claude Huriez University Hospital, Lille, France.
⁸ Department of Surgery, Catharina Cancer Institute, Eindhoven, The Netherlands.
⁹ Department of General and Digestive Surgery, Hautepierre Hospital, Strasbourg University Hospital, Strasbourg, France.
¹⁰ Department of Digestive Surgery, Dupuytren University Hospital, Limoges, France.
¹¹ XLIM, UMR 7252, CNRS, Limoges, France.
¹² Hospices Civils de Lyon, Hôpital Lyon Sud, Service de Recherche et d'Epidémiologie Cliniques, Pierre-Bénite, France.
¹³ Department of General Surgery, Emergency, and New Technologies, San Camillo Forlanini Hospital, Rome, Italy.
¹⁴ Peritoneal Malignancy Unit, Basingstoke Hospital, Basingstoke, UK.
¹⁵ Department of Gynecological Oncology, Heidelberg Medizinische Klinik, Heidelberg, Germany.
¹⁶ UCD Gynaecological Oncology Group, UCD School of Medicine, Mater Misericordiae University Hospital, Dublin, Ireland.
¹⁷ Department of Gynecological Oncology, Clinique du Fief de Grimoire, Poitiers, Cedex, France.
¹⁸ Department of Gynecological Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
¹⁹ Department of Surgical Oncology, Hôpita Lyon Sud, Hospices Civils de Lyon, Lyon, France.
²⁰ Department of General and Visceral Surgery, Hospital Barmherzige Brüder, Regensburg, Germany.
²¹ Peritoneal Surface Malignancy and HIPEC Skåne University Hospital, Lunds University Sweden, Lunds, Sweden.
²² MD Anderson Cancer Center, Madrid, Spain.
²³ Department of General Surgery and Surgical Oncology, King Khalid Hospital, Najran, Saudi Arabia.
²⁴ Department of Surgical Oncology, Montpellier Cancer Institute, University of Montpellier, Montpellier, France.
²⁵ Chirurgische Klinik, Campus Charité Mitte, Charité-Universitätsmedizin, Berlin, Germany.

PMID: 39285659
DOI: 10.1002/jso.27885

Abstract

The 2022 PSOGI (Peritoneal Surface Oncology Group International) and RENAPE (French Network for Rare Peritoneal Malignancies) consensus on hyperthermic intraperitoneal chemotherapy (HIPEC) was a comprehensive effort aimed at standardizing treatment protocols for various peritoneal malignancies. This initiative is critical due to the wide range of technical variations in HIPEC procedures and the resulting need for standardization to ensure consistent and effective patient care and meaningful audit of multicenter data.

Keywords: HIPEC regimens; consensus; hyperthermic intraperitoneal chemotherapy; peritoneal surface malignancies.

Publication types

Review